Inflamatory Pseudotumor of the Bladder: A Histopathological Diagnostic Challenge from Its Malignant Variant. by Muhammad Akbar, et al.
Inflammatory pseudotumour of bladder                                                                                                          Muhammad Akbar et al. 
 
46 
 
 
 
 
 
 
Inflamatory Pseudotumor of the Bladder: A Histopathological Diagnostic 
Challenge from Its Malignant Variant 
 
Muhammad Akbar1, Praveen S1 (), Christopher HCK1, Goh EH1, Swaminathan2, Zulkifli MZ
 
1 
1
 Kuala Lumpur, Malaysia. 
Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia Medical Center (UKMMC),  
2
 Malaysia 
 
Department of Pathology, Universiti Kebangsaan Malaysia Medical Center (UKMMC), Kuala Lumpur,  
 
Abstract 
 
Inflammatory Pseudotumor (IP) of bladder is one of a variety of lesions which may arise from spindle cell lesions in 
the bladder. It is benign in nature compared to the other end of the spectrum of spindle cell lesions, such as sarcoma, 
sarcomatoid carcinoma and leiomyosarcoma. The diagnosis of IP and its differentiation from a malignant pathology 
is a diagnostic dilemma for Urologist and Pathologist as both entities share certain similar morphological and histo-
pathological appearance as well as immuno-histo chemistry staining. It is however crucial to avoid misdiagnosis as 
the treatment option varies significantly between a radical or partial cystectomy with future surveillance cystoscopes. 
Hereby, we highlight a case of a benign variant of spindle cell tumour of bladder which needed second pathology 
review for confirmation and thus avoiding a radical cystectomy. We also review the literature on its presentation and 
emphasis characteristics differentiating a benign from a malignant pathology. 
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Introduction 
 
Spindle cell tumors of the bladder is not uncommon 
and it consists of a spectrum of benign to malignant 
variety. Inflamatory pseudotumor (IP) is a benign type 
of spindle cell tumor and is rare (1). It was originally 
described by Roth et al in 1980 (2). Patients usually 
present with painless hematuria, recurrent cystitis (3) 
and rarely urinary obstruction resulting from the large 
bladder mass. Uncommon presentations include 
bladder calculi and large palpable abdominal mass (4). 
It has no sex predilection and has been reported in age 
ranges from 15 to 74 years (3). However it is 
commonly seen in younger women (1). Cystoscopy 
findings may reveal a polypoidal , intraluminal or a 
submucosal mass. The dilemma of diagnosis in IP is in 
its certain similar histopathology characteristics with a 
malignant sarcoma. This dilemma is shared by the 
urologist as well since subsequent management differs 
greatly between a radical cystectomy or a local 
resection and regular surveillance. Here we report a 
middle age lady with the above mentioned problem 
and review the literature on pathological 
characteristics which can aid to differentiate a benign 
IP from a malignant sarcoma. 
 
Case Report  
 
A 46- year- old lady presented with painless hematuria 
of one month duration to a private medical center. 
There were no symptoms to suggest urinary tract 
infection (UTI) or previous episodes of UTI. There 
Case Report 
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Figure 1: A) Proliferation of slender spindle cells (high power x 10), B) Myxoid and oedematous stroma (high power x 10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: A) Foci of inflammatory mononuclear component composed of lymphocytes and plasma cells (high power x 40), B) 
areas of vessels proliferation (high power x 40) 
 
was no previous bladder or urinary tract 
instrumentation or trauma. There were no 
constitutional symptoms. Cystoscopy revealed a 3 x 2 
cm polypoidal mass arising from the left lateral wall of 
the bladder with superficial ulceration. In view of a 
possible malignant pathology a transurethral resection 
of bladder tumour (TURBT) was performed. 
Ultrasound of the upper urinary tracts were normal.  
 
An initial histopathology diagnosis of a malignant 
spindle cell tumour of the bladder was made. The 
patient was offered cystectomy with an ileal conduit 
reconstruction. The patient sought a second opinion in 
our medical institution and the histopathology slides 
were reviewed. It showed that the mass consisted of 
proliferation of slender spindle cells (Fig. 1A) in a 
myxoid and oedematous stroma (Fig. 1B). There were 
foci of inflammatory mono-nuclear cells composed of 
lymphocytes and plasma cells (Fig. 2A) and micro 
vessels proliferation (Fig. 2B). Mitotic count is one per 
10 high power field (hpf). Immuno-histo-chemistry 
staining showed positivity to vimentin, S100, CK and 
CD31. It was negative for MyoD1, Desmin, HMWCK 
and ALK. With this, a diagnosis of a benign 
inflammatory pseudotumour of the bladder was 
diagnosed and the patient was spared a radical 
cystectomy. A repeat cystoscopy six weeks after 
TURBT showed no recurrence of tumour. The patient is 
currently on three monthly surveillance cystoscopy with 
no recurrences detected over the past one year.  
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Discussion 
 
A variety of names have been given for the benign 
variant of bladder spindle cell tumour  such as IP, 
inflammatory myofibroblastic tumour (IMT), pseudo-
sarcomatous myofibroblastic proliferation (PMP) and 
post operative spindle cell nodule (PSCN) (5). 
Malignant variant of them include leiomyosarcoma, 
rhabdomyoarcoma and spindle cell carcinoma. All the 
nomenclature given above reflect the fundamental 
pathological abnormality detected in these lesions that 
is the presence of an inflammatory process, 
proliferation of fibro-collagenous tissues, abundant 
spindle cells and high vascularity (1). 
 
Spindle cell tumour of bladder is reportedly associated 
with neurogenic bladder and those with a history of 
bladder instrumentation (1). The term PSCN is applied 
for lesions similar to IP that arises within a 3 month 
time frame from bladder instrumentation. This 
produces an inflammatory pseudotumour which arises 
from the submucosa of the bladder under a normal 
transitional cell epithelium (6). 
 
IP is benign, does not metastasis and is not a pre 
malignant condition. It is associated mortality 
previously reported was from a large bladder mass 
causing urinary obstruction with urosepesis. However, 
synchronous urothelial carcinoma has been reported 
with IP (7). Hence surveillance cystoscopy is 
necessary even if IP is diagnosed. 
 
IP was initially considered as a non-neoplastic lesion 
and represented an aberrant inflammatory response. 
The dilemma occurs as several aspects of IP are 
neoplastic in nature, that in its potential for 
recurrences, possible multifocal involvement, 
infiltrative local growth and vascular invasion. 
Additionally it may show muscularis propria 
involvement (3). 
 
Pathological characteristics that support a benign IP 
include the absence of nuclear hyperchromasia, absence 
of atypical mitosis and absence of necrosis at tumour - 
detrusor muscle interface. Benign IP however may 
demonstrate mitosis of 0-1 per 10 high power field (hpf) 
as compared to sarcoma (1-16 per 10hpf) (1). Presence 
of necrosis, myxoid degeneration and nuclear atypia 
were the best criteria to differentiate a benign from 
malignant pathology. The malignant sarcoma is 
reportedly to have less prominent microvasculature and 
without a history of prior instrumentation. 
 
Immunohistochemistry staining aids slightly in 
differentiating the two.  IP demonstrates positivity 
towards vimentin and actin. Regarding sarcoma p53 is 
the common denominator and is absent in IP (5). Other 
markers like desmin, is usually not positive in IP. 
Fibronectin has been reported to be specific to IMT.  
 
Hematuria is a common presentation in IP lesions as in 
our patient. It is due to its high tumour vascularity and 
associated superficial ulceration (1). Our patient did 
not have any history of bladder instrumentation 
making PSCN an unlikely diagnosis. 
 
Tamoxifen was found to be effective for IP. It acts by 
modulating production of growth factors such as 
epidermal growth factor, insulin like growth factor and 
transforming growth factor. This results in reduction 
of fibroblast and spindle cell proliferation (1).  
 
Surgery, however, is the main stay of treatment. 
Surgical treatment of IP is usually sufficient with a 
transurethral resection. Recurrence is uncommon 
though it is thought to be more of a case of incomplete 
resection rather than a true recurrence itself. 
Surveillance cystoscope is recommended to look out 
for local recurrence and pick up any missed concurrent 
malignant lesion. The surveillance protocol would 
avoid any mismanagement if a wrong initial 
pathtological diagnosis was made.  
 
Our patient avoided a radical cystectomy and its 
associated morbidities after careful re-inspection of the 
pathology specimens. Currently the surveillance 
protocol has yield no recurrence over the past one year. 
 
Conclusion 
 
IP of the bladder is a benign condition that has a good 
prognosis and should be carefully diagnosed and 
differentiated from its malignant counter-part, spindle 
cell sarcoma.  However, the complexity and large 
variant of spindle cell lesions poses a diagnostic 
challenge and potentiates a misdiagnosis. Here, we 
stress of the importance and awareness in 
differentiating benign and malignant bladder spindle 
cell lesion by careful inspection of the presenting 
history, clinical presentation, it’s pathological and 
immunohistochemistry characteristics to avoid error in 
management. 
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